The NEST Act amends Title V of the Social Security Act to authorize the purchase, acquisition, and distribution of newborn supply kits as a special project of regional and national significance. The bill defines required kit contents (including a blood pressure monitor and postpartum supplies), directs the HHS Secretary to award grants or cooperative agreements to multi‑state nonprofits, FQHCs, Tribal organizations, and birthing hospitals, and creates distribution priorities for areas of greatest maternal need.
Practically, the bill lets the Secretary reserve up to $5 million per year from Title V funds for fiscal years 2026–2030 to procure and distribute kits, requires partnerships with local organizations to reach diverse geographies and families under 185% of the federal poverty line, and mandates interim and final reports that include disaggregated data and outcome analysis. For compliance officers and program managers, the bill creates new procurement, partnership, targeting, and reporting obligations layered onto existing Title V operations.
At a Glance
What It Does
The bill adds newborn supply kits to the list of Title V special projects and allows the HHS Secretary to reserve up to $5 million per fiscal year (FY2026–2030) to buy and distribute those kits via grants or cooperative agreements. It specifies kit contents, requires distribution prioritization for high‑need areas and families ≤185% of the poverty line, and mandates reporting on reach and health outcomes.
Who It Affects
Affected entities include the Maternal and Child Health Bureau/Title V administrators at HHS, multi‑state nonprofits and community organizations, federally qualified health centers, Tribal organizations, and birthing hospitals that will serve as grant recipients or distribution partners. Manufacturers and suppliers of infant and postpartum goods will face new procurement opportunities and specifications.
Why It Matters
This bill codifies a commodity‑based intervention into a federal maternal‑child health program and ties federal Title V resources to direct material supports and data collection. It creates a narrowly capped federal funding stream with explicit equity targeting and reporting requirements — a model that agencies and providers must operationalize quickly if funded.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The NEST Act inserts newborn supply kits into Title V’s toolbox by changing statutory language to permit the Secretary to include procurement and distribution of kits as special projects. Rather than create a new entitlement or block grant, it permits the Secretary to set aside a capped portion of existing Title V funds for grants or cooperative agreements.
The bill names eligible recipients — organizations with multi‑state reach, federally qualified health centers, Tribal entities, and birthing hospitals — and requires those recipients to partner with local groups for distribution.
The legislation defines a baseline list of kit contents that mixes infant essentials (diapers, wipes, blankets, thermometers) with postpartum supplies and informational materials aimed at maternal health (breastfeeding resources, hotline referrals, educational materials on low‑dose aspirin use for specific pregnancy risks). Notably, it requires inclusion of a blood pressure monitor and leaves room for the Secretary to add additional items deemed necessary for postpartum and infant health.On targeting and equity, the bill directs grantees to maximize geographic diversity while prioritizing maternity care deserts, rural communities, regions with high maternal mortality (the bill cites the Delta region as an example), and families at or below 185% of the federal poverty line.
Operationally, that means recipients must build local partnerships, design distribution plans that favor higher‑need areas, and document how allocations meet those priorities.The NEST Act includes concrete accountability: the Secretary must report to four congressional committees with an interim report within one year of the first award (including disaggregated demographics and geographic coverage) and a final report within 180 days after the last award in FY2030 assessing maternal and infant health outcomes. Those reporting obligations will drive data collection requirements for grantees and create a record intended to show whether commodity distribution affected health metrics.
The Five Things You Need to Know
The bill adds a statutory definition of a 'newborn supply kit' that explicitly includes a blood pressure monitor and educational material on low‑dose aspirin for pregnancy‑related risks.
The Secretary may reserve up to $5,000,000 per fiscal year from Title V funds for fiscal years 2026 through 2030 to buy and distribute kits via grants or cooperative agreements.
Only specified recipients — nonprofit entities with a multi‑state presence, FQHCs, Tribal organizations, and birthing hospitals — may receive grants or cooperative agreements to procure kits.
Grantees must partner with local organizations, seek geographic diversity, and give priority to maternity care deserts, rural areas, regions with high maternal mortality (e.g.
the Delta), and families with income ≤185% of the federal poverty line.
The Secretary must deliver an interim report within one year of the first award with disaggregated beneficiary data and a final outcomes report within 180 days after the last FY2030 award to four congressional committees.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Designates the Act as the 'Newborns Essentials Support Toolkit Act' or 'NEST Act.' This is a formal naming provision with no operational effect other than how the bill will be cited in subsequent references and reports.
Authorize Title V for newborn kit procurement
Modifies the statutory list of allowed special project activities under Title V to permit the 'purchase, acquisition, and distribution' of newborn supply kits. The mechanical change gives the Secretary a clear statutory hook to use Title V funds for commodities rather than only programs or services and is necessary to authorize grants and cooperative agreements described later in the bill.
Defines minimum kit contents and flexibility
Specifies that kits must include infant essentials (diapers, wipes, blankets, thermometers), postpartum supplies (pads, cold packs, lotion), breastfeeding supports and informational resources (including hotline referrals), a blood pressure monitor, and evidence‑based educational items such as materials about low‑dose aspirin for certain pregnancy risks. The Secretary retains discretion to add 'other items necessary' which creates a baseline standard plus regulatory flexibility for procurement and clinical alignment.
Creates a $5M/year funding reservation for FY2026–2030
Revises the funding provisions to permit the Secretary to reserve up to $5,000,000 annually from Title V funds for fiscal years 2026 through 2030 specifically for newborn kit projects. The set‑aside is permissive ('may reserve') and capped, meaning use of Title V funds for kits is limited in scale and discretionary each year rather than automatic or open‑ended.
Grant, procurement, and distribution rules
Directs the Secretary to award grants or cooperative agreements to eligible entities (multi‑state nonprofits, FQHCs, Tribal organizations, birthing hospitals) for procurement of kits, and conditions distribution on partnerships with local organizations. It imposes prioritization requirements — geographic diversity plus priority for maternity care deserts, rural communities, high maternal mortality regions, and families ≤185% FPL — and thereby embeds equity targeting into recipient selection and distribution plans.
Interim and final reporting to specific congressional committees
Requires an interim report within one year of the first award that includes number served (disaggregated by race, income, and household size), geographic coverage, beneficiary feedback, and other items the Secretary finds necessary. It also requires a final report within 180 days after the last FY2030 award assessing maternal and infant health outcomes. The bill names four congressional committees that will receive the reports, tying program performance to legislative oversight and future funding decisions.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Low‑income postpartum mothers and newborns: The kit targets families at or below 185% of the federal poverty line and supplies immediate material supports (diapers, postpartum care items, BP monitors) that can reduce short‑term gaps in care and monitoring.
- Community health providers and FQHCs: Eligible health centers and community organizations can leverage grants to expand discharge resources and build local distribution networks, potentially improving postpartum follow‑up and breastfeeding support.
- Tribal communities and Tribal organizations: The bill explicitly lists Tribal organizations as eligible recipients, creating a funding pathway to address maternal and infant needs in Native communities where access may be limited.
- Birthing hospitals: Hospitals that participate can provide standardized take‑home kits at discharge, which may reduce early postpartum complications and improve patient satisfaction with discharge planning.
- Public health programs and data analysts: Required reporting and disaggregated data will provide new information on distribution reach and outcomes that can inform future maternal health interventions and resource allocation.
Who Bears the Cost
- Title V program and its existing grantees: Up to $5M/year is available only by reservation from Title V funds, which could reduce funding available for other Title V activities unless appropriations increase.
- HHS/administration (Maternal and Child Health Bureau): The agency must design procurement rules, run the grant competition, monitor distribution, and compile statutorily required reports, creating administrative workload and likely requiring new staff time or reallocation.
- Nonprofit grantees and distribution partners: Recipients must meet partnership, geographic‑diversity, prioritization, and data collection requirements, which will impose administrative costs and compliance obligations that smaller local organizations may struggle to absorb.
- Manufacturers and suppliers: Suppliers will need to meet federal procurement specifications (including medical device considerations for blood pressure monitors) and adjust production and logistics to fulfill grant‑funded orders.
- State and local partners: Local organizations asked to partner for distribution will need to handle inventory, storage, and last‑mile distribution logistics, often without direct federal reimbursement beyond the grants.
Key Issues
The Core Tension
The central dilemma is whether a modest, time‑limited investment in material supports—diapers, postpartum supplies, and BP monitors—delivered through Title V grants can produce measurable improvements in maternal and infant outcomes, or whether those scarce Title V dollars would yield greater benefit if invested in clinical capacity, workforce, or systemic supports; the bill favors quick, tangible assistance but leaves open whether that approach is the most effective path to long‑term maternal health gains.
Two implementation and policy questions will determine how meaningful the NEST Act is in practice. First, the funding cap — a permissive reservation of up to $5 million per year for five years — is small relative to national birth volumes and the scale of maternal health disparities.
That means programs will need to prioritize tightly, and the bill’s equity targeting will drive difficult allocation choices about which communities and families receive kits.
Second, several operational ambiguities create real implementation work: the Secretary’s authority to add 'other items' to kits, how blood pressure monitors will be sourced and whether they trigger additional medical device procurement rules or liability concerns, and how grantees must document 'feedback' and health outcomes in a way that supports the required final outcomes report. The reporting regime demands outcome attribution from a primarily commodity distribution program; isolating the impact of kits on maternal and infant health will require robust evaluation design and resources that the statute does not fund explicitly.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.